Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorCombined Modality TherapyLeukapheresisAntigens, CD34Hematologic NeoplasmsBone Marrow TransplantationStem Cell TransplantationBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideBone MarrowTreatment OutcomeGraft vs Host DiseaseMyeloablative AgonistsBusulfanHematopoietic Stem CellsLymphoma, Non-HodgkinRemission InductionGraft SurvivalAntineoplastic Agents, AlkylatingRecurrenceEtoposideThiotepaBone Marrow CellsSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideHematopoiesisAmyloidosisBoronic AcidsStem CellsPyrazinesSurvival RateRetrospective StudiesThalidomideCytarabineDexamethasoneHodgkin DiseaseTransplantation ChimeraCord Blood Stem Cell TransplantationPrednisoneSurvival AnalysisTime FactorsTissue DonorsDoxorubicinNeoplasmsWhole-Body IrradiationInfectionAntineoplastic AgentsBone Marrow PurgingLymphoma, T-CellHistocompatibilityPlatelet CountPOEMS SyndromeHistocompatibility TestingLeukemia, Myeloid, AcuteFollow-Up StudiesImmunosuppressive AgentsLeukemiaTransplantation, IsogeneicCarboplatinBlood Cell CountPlasma CellsRecombinant ProteinsImmunophenotypingVidarabineBlood CellsLymphomaPrognosisProspective StudiesFatal OutcomeBone Marrow DiseasesFlow CytometryBone and BonesCytomegalovirus InfectionsGraft vs Leukemia EffectAnemia, AplasticFeasibility StudiesMyelodysplastic SyndromesMyeloma ProteinsT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocytes, MononuclearParaproteinemiasLymphocyte DepletionHematologic DiseasesBlood Transfusion, AutologousCell SeparationPrecursor Cell Lymphoblastic Leukemia-Lymphoma